Effect of Azithromycin in Preventing Radiation-Induced Lung Injury in Mice

F. Tang,R. Li,J. Xue,L. Deng,Y. Lu

DOI: https://doi.org/10.1016/j.ijrobp.2016.06.2098

2016-01-01

Abstract:Radiation-induced lung injury (RILI) is a common and major obstacle in thoracic cancer radiotherapy, resulting in considerable morbidity and limiting the dose of radiation. However, an effective treatment option has not yet been established. Azithromycin (AZM) is a second-generation macrolide antibiotic with broad-spectrum efficacy against gram-positive, gram-negative, and atypical pathogens. In addition to antibiotic activity, several studies have established that AZM possesses anti-inflammatory and immunomodulatory properties, which attains very high and durable lung concentrations. Thus, this study aimed to investigate the effects of azithromycin in RILI with a mouse model. In this study, Eight-week-old female C57BL/6 mice were given a single thoracic irradiation of 16 Gy. The head, abdomen, and extremities were shielded with lead strips. Non-irradiated mice were treated in the same manner but without radiation. One day before radiation, mice received 100 mg/kg azithromycin by gavage or the same volume of vehicle alone (5 ml/kg) via oral gavage directly into the stomach in the Control group (non-irradiated control + vehicle) and RT group (irradiation + vehicle). After irradiation, animals were administered with the original protocol once daily until they were killed under anesthesia. The lung histopathologic findings, the malondialdehyde (MDA, an indicator of oxidative damage) levels and the concentrations of pro-inflammatory and pro-fibrotic cytokines in plasma were assessed on 4 and 16 weeks after irradiation. In addition, the pro-inflammatory and pro-fibrotic cytokine gene expression in lung tissue were evaluated on 1、2、4 and 16 weeks after irradiation. Administered with azithromycin significantly decreased radiation-induced alveolar wall thickness, alleviated interstitial edema, and attenuated collagen deposition as shown by H&E and Masson staining. The MDA levels significantly reduced in azithromycin treatment mice on 4 and 16 weeks. Azithromycin also down-regulated the concentrations in plasma and the mRNA expression of IL-1β, IL-6, TNF-α and TGF-β1 in lung tissue on each time points. In addition, AZM attenuated the irradiation-induced increases in the mRNA expression of fibrotic markers (α-SMA and Col1a1) in lung tissue. Azithromycin treatment mitigated the radiation-induced lung injury possibly by anti-inflammation and anti-fibrotic effects.